$RICK $SANM $DO: Report: Developing Opportunities within Lexicon Pharmaceuticals …

Date: Monday, November 12th, 2018

Stock(s) mentioned: , ,

Source: Benzinga (https://www.benzinga.com)

Summary: … RCI Hospitality Holdings, Inc. (NASDAQ:RICK), Sanmina Corporation (NASDAQ:SANM), Diamond Offshore Drilling, Inc. (NYSE:DO), and Cerus Corporation …

Full article address: https://www.benzinga.com/pressreleases/18/11/g12677347/report-developing-opportunities-within-lexicon-pharmaceuticals-cray-rc

Related News:

$RICK: EQUITY ALERT: Rosen Law Firm Announces Investigation of …

$RICK: INVESTOR ALERT: Law Offices of Howard G. Smith Announces …

$RICK: RCI Will Not Timely File 2Q19 10-Q; Reports Preliminary Results

$SKYW $ACBI $HLT $RICK $MUR: 5 Top Stocks to Blossom This Spring Season

$RICK: RCI Declares Regular Quarterly Cash Dividend on Common Stock

$RICK: RCI Hospitality Holdings, Inc. (RICK) CEO Eric Langan on Q1 2019 …

$RICK: RCI Reports 1Q19 Results and Files 10-Q

$RICK: Rick’s Cabaret Expands to 9-Unit National Chain of Quality …

$RICK: RCI to Report 1Q19 Results, Hold Conference Call & “Meet …

$RICK: RCI Hospitality Holdings, Inc. (RICK) Q1 2019 Sales Conference …

$RICK: RCI Reports 1Q19 Club & Restaurant Total Sales Up 6.5%

Latest News:

$AVTR $FSLY $LK $LYFT $PINS $UBER: Why the IPO Boom Will Continue

$SBUX: Millions of Americans Could Miss Work Tomorrow After the ‘Game of Thrones’ Finale

$AMZN $OXY $APC $WFC $SRE: Want to invest like Warren Buffett? Here are the ins and outs of buying preferred stock

$TSLA $GM: Tesla fires could dampen electric car sales as industry ramps up EV production, auto analysts say

$ROKU $GH $CVNA: 3 Stocks That Have Doubled in 2019 — Are They Still Buys?

$AXSM: Here’s Why You’ll Regret Ignoring This Biotech Stock Rocket

$MMM: Market Loses Its Hopium-Induced High, Falls 4 Weeks Straight

$TLRY $ACB: How Did Tilray Stack Up to the Competition?

$BAH: Booz Allen Has Been a Big Winner, but the Best May Be Yet to Come

$ICPT $GILD: Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences

$JFIN: 3 Reasons iQiyi Held Up Better Than Baidu